title: When treating patients with schizophrenia, what clinical points should be considered if lamotrigine is chosen to augment clozapine?
authors.affiliation: Psychopharmacology Research Unit, Department of Psychiatry, Dalhousie University, Queen Elizabeth II Health Sciences Center, Halifax, NS.
authors.forename: S M
authors.initials: SM
authors.lastname: Dursun
authors.forename: S
authors.initials: S
authors.lastname: Devarajan
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003024:Clozapine / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D000077213:Lamotrigine; D017410:Practice Guidelines as Topic; D012559:Schizophrenia / Q000188:drug therapy*; D014227:Triazines / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D014150:Antipsychotic Agents; D014227:Triazines; D003024:Clozapine; D000077213:Lamotrigine